Chemed Co. (NYSE:CHE) Shares Sold by Kennedy Capital Management LLC

Kennedy Capital Management LLC trimmed its holdings in shares of Chemed Co. (NYSE:CHE) by 2.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 24,723 shares of the company’s stock after selling 542 shares during the period. Kennedy Capital Management LLC’s holdings in Chemed were worth $13,098,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CHE. Raymond James Financial Inc. acquired a new position in Chemed in the 4th quarter valued at $42,023,000. HighTower Advisors LLC boosted its holdings in shares of Chemed by 78.0% in the third quarter. HighTower Advisors LLC now owns 3,730 shares of the company’s stock valued at $2,246,000 after buying an additional 1,634 shares during the period. Geode Capital Management LLC increased its stake in Chemed by 4.9% in the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock valued at $201,820,000 after buying an additional 15,791 shares during the last quarter. Signal Advisors Wealth LLC grew its position in shares of Chemed by 60.7% in the 4th quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company’s stock valued at $2,647,000 after acquiring an additional 1,886 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Chemed by 10.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 136,182 shares of the company’s stock valued at $72,149,000 after acquiring an additional 13,394 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the sale, the chief executive officer now directly owns 102,679 shares of the company’s stock, valued at approximately $60,957,441.93. The trade was a 1.91 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 3.32% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

CHE has been the subject of a number of research reports. Royal Bank of Canada raised their price objective on shares of Chemed from $633.00 to $667.00 and gave the company an “outperform” rating in a report on Friday, March 14th. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th.

Chemed Price Performance

Shares of NYSE:CHE opened at $587.42 on Thursday. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $627.12. The business has a fifty day moving average price of $581.75 and a 200-day moving average price of $567.98. The company has a market capitalization of $8.60 billion, a PE ratio of 29.68, a PEG ratio of 2.15 and a beta of 0.49.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.34%. The ex-dividend date was Monday, February 24th. Chemed’s dividend payout ratio (DPR) is 10.05%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.